A forum for researchers, students and applicants in the field of cyclodextrin technology
The aim of this study was to evaluate the interaction between catanionic vesicles based on amphiphilic cyclodextrins (ModCBHD) and DNA–Doxorubicin
Phytocannabinoids possess anticancer properties, as established in vitro and in vivo. However, they are characterized by high lipophilicity. To improve
In the last decade, nanotechnological progress has generated new opportunities to improve the safety and efficacy of conventional anticancer therapies.
This review of Rincón-López et al. (2021) was published in the special issue Pharmaceutical and Biomedical Applications of Cyclodextrins and
The team of Motoyama in Kumamoto has recently published new results on folate-appended CDs in leukemia and ovarian cancer (1,2).
A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid
A novel folate receptor-targeted β-cyclodextrin drug delivery vehicle was constructed to improve the bioavailability, biosafety, and drug loading capacity of
Wan et al. (2021) published on the synthesis and potential utilization of β-CD modified with hyperbranced polyglycerol polymer and decorated
The antibacterial activity of triazole functionalized cyclodextrin (CD.Click) and cyclodextrin-triazole-titanium based nanocomposite (CD.COM) was evaluated. The results indicated that CD.Click
Cytokines are key components of the immune system and play pivotal roles in anticancer immune response. Cytokines as either therapeutic
